Editorial Policies

Aims and Scope

The subjects: neurology, psychiatry, neurosurgery, addiction medicine, psychotherapy, medical psychology.

 

Sections

Frontiers papers

раскрывают какую-либо проблему

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Original studies

содержат результаты конкретных научных разработок

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Lectures

включают разделы об истории вопроса, этиологии, клиники и пр. или построены по типу клинического разбора с раскрытием темы

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Recommendation for practitioners

рекомендации в вопросах диагностики, лечения, реабилитации и т.п

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Наблюдения из практики

обобщения собственного опыта, оригинальные наблюдения и др.

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Review papers

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Discussions

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Personalies

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Brief communications

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Obituary

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Reviews

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Anniversary

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Письмо в редакцию

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Review procedure includes the following steps:

1) Examination of the article. Within five working days from receipt of the manuscript to the editor, an initial assessment is carried out for compliance with the requirements of the rules and the theme of the magazine. Any discrepancies to the rules of the author (s) shall notify the rejection of work, indicating the reasons. At this stage articles which are rejected are not reviewed.

2) Peer review. If the manuscript is recognized as covering relevant issues of the magazine and its requirements, it is sent for review to one or two external reviewers at the discretion of the editorial board; internal reviewers are the chief editor, deputy editor and science editor. External review is carried out by specialists with the following: profile, having a non-scientific degree, having no financial or any other relationship with the authors and editors of the magazine. The review of articles is performed on a voluntary basis and free of charge. For external reviewers, the manuscript is sent without noting the authors and their organizations ("blind" review). Reviewers within two to three weeks from the date of receipt of the manuscript should render in writing a reasoned opinion on the possibility of its publication in the present form, and the presence of claims in the manuscript. .

3) Evaluation of the editorial board. This is implemented for articles being prepared for publication in the next issue of the magazine. Meetings of the Editorial Board are held once every 2 months (including in the form of Internet-conference). The editorial board approves the list of articles to be published in the current issue of the journal. It has the right to reject an article, have it peer reviewed, if the editorial board raised questions on some aspects of the article, or submit it for an additional external review.

Terms of peer review between the date of receipt of the manuscript to the editor and the editorial board decision are in each case determined by the editorial staff with the view to creating conditions for the rapid publication of the most articles. The maximum period of review is 2 months.

The final decision on the possibility of publishing the manuscript is made by the chief editor or deputy editor. All manuscripts which receive the approval of the chief editor and deputy editor are sent for the scientific and literary adaptations, page-proofs and publication. The editors reserve the right to edit (including reduction) submitted articles and their titles.

The procedure for informing the authors about the results of the review

  • If a positive opinion about the possibility of publication of the manuscript in the Journal is made by the Reviewers, the author (s) shall be notified by e-mail message and the manuscript shall be made ready for publication.
  • A negative review, and the review made by reviewers with questions or comments is compulsorily sent to the author (s) of the manuscript. Author (s) should be made to respond to all the reviewers questions, comments and recommendations, and, with their consent, shall make appropriate corrections to the original manuscript. In case of disagreement by the author (s) with the opinion of the reviewers, it must convincingly justify their point of view. The corrected the manuscript by the author(s) and his response shall be sent to reviewers for review.

Not allowed to be published:

  • Article not designed in accordance with the requirements by which the authors waive technical revision of the article;
  • Articles by authors which are not revised in accordance with guidance of the reviewer or do not refute the arguments of the reviewer.

Rejected articles revised by the authors can be re-admitted to the editor, they are treated in a general manner.

 

Publication Frequency

Neurological Bulletin is a quarterly journal. Additional publications, such as conference proceedings,  special issues, and supplemental issues are possible. 

 

Author Self-Archiving

The journal is compliant with Green Open Access mode (formerly known as Open Self-Archiving) for articles distribution.

Terms and definitions

We use the following terms and definitions:

  • Preprint: An early version of an article prior to the version submitted for publication in a journal. Theses and dissertations are considered to be preprints.
  • SMUR (Submitted Manuscript Under Review): The version of the article that is under formal review for inclusion in the journal.
  • AM (Accepted Manuscript): The version of the article that has been accepted for publication. This version may include revisions resulting from peer review but may be subject to further modification by Pharmarus Print Media (for example, copyediting and typesetting).
  • VoR (Version of Record): The version that is formally published. This not includes any Online First article that is formally identified as being published online before the compilation of a journal issue. The VoR includes any post-publication corrections.
  • Personal webpage: Web pages created by you, about you and your research which are hosted on a non-commercial website (such as your institute’s website). Personal profile pages in commercial sharing sites (such as ResearchGate, Academia.edu and Facebook) are not considered to be personal web pages.
  • Department or institutional repository: Web pages hosted by an academic or research institute or department to provide access to the work to promote and the activities of the institute or department, at all times operating for a non-commercial purpose.
  • Subject repository: Web pages hosted by an organization to provide access to the work from researchers working in a subject or range of subjects, at all times operating for a non-commercial purpose.
  • Commercial and non-commercialCommercial means any activity for direct or indirect financial gain. When considering whether a use is commercial or non-commercial, we look at the nature of the activity rather than the nature of the site or organization performing the activity.


What can be self-archived, where and when

 

 

Personal
web page

Department or institutional repository

Non-commercial subject repository
(e.g. PubMed Central)

Commercial repository or social media site
(e.g. ResearchGate, Academia.edu, SSRN)

Preprint,
SMUR

At any time

At any time

At any time

At any time

AM

On acceptance

On acceptance

On acceptance

Abstract only plus link to VoR on https://journals.eco-vector.com/ 

VoR

Abstract only plus link to VoR on https://journals.eco-vector.com/ 

Abstract only plus link to VoR on https://journals.eco-vector.com/ 

Abstract only plus link to VoR on https://journals.eco-vector.com/ 

Abstract only plus link to VoR on https://journals.eco-vector.com/ 

 

Plan S compliance

Our Green OA policy is not compatible with Plan S, and our License to Publish agreements with authors may conflict with authors' agreements with their cOAlition S funders. Authors should publish as Gold OA in order to be compliant with Plan S.

Creative Commons and other end-user licenses

Preprints and SMURs can be made publicly accessible under any license terms the authors choose. We recommend a Creative Commons CC-BY or a more restrictive CC license.

Accepted Manuscripts can be made accessible under a Creative Commons CC-BY-NC-ND license or equivalent, but not a more permissive license. We do not allow AMs to be made accessible under a CC-BY license, for example.

Third-party material

Before posting articles online, authors should ensure they have the appropriate permission to include any third party content. When posting articles under a Creative Commons license, the permission should allow the third-party material to be included either (i) under the Creative Commons license or (ii) clearly indicated as being protected by third party copyright, with a clear notice that it cannot be reused without further permissions clearance from the identified third-party rights holder.

Closed deposits and embargo periods

Articles can be deposited in repositories before publication provided the content is only accessible to repository administration staff. This is sometimes referred to as ‘closed deposit’.

Metadata about the article (for example the article title, abstract, and journal citation) can be made public as soon as the article is published. The full text must not be made public before the embargo ends.

Any applicable embargo period starts from the date the Version of Record is first published online as part of a journal’s issue.

Posting content in repositories

We require repositories to include:

  • If an article has not yet been published, a clear statement that the material has been accepted for publication in a revised form, with a link to the journal’s site on https://journals.eco-vector.com/.
  • For all published articles, a link to the article’s Version of Record in https://journals.eco-vector.com/ – for example, via a DOI-based link.
  • A clear statement about the license terms under which the posted version of the article is deposited.

Example statements are:

  • This article has been published in a revised form in Neurology Bulletin [http://doi.org/XXX]. This version is free to view and download for private research and study only. Not for re-distribution or re-use. © copyright holder.
  • This article has been published in a revised form in Neurology Bulletin [http://doi.org/XXX]. This version is published under a Creative Commons CC-BY-NC-ND. No commercial re-distribution or re-use allowed. Derivative works cannot be distributed. © copyright holder.


Citing content in repositories

When citing an Accepted Manuscript or an earlier version of an article, we request that readers also cite the Version of Record with a DOI link, for example: Subsequently published in revised form in Neurology Bulletin [http://doi.org/XXX].

 

Issue Purchase

Readers without a subscription may still purchase individual issues. The following payment options and fees are available.

Access for an Issue: 35.00 (USD)

You can purchase the access for all articles published in one issue. Access to articles will be provide for an unlimited time.

Access to issue allows you to read, download and print full text (PDF and HTML) of all articles, but does not allow to distribute, copy or reproduce articles materials until the end of the embargo period (3 years) since the publication of the article).

 

Article Purchase

Readers without a subscription may still purchase individual articles. The following payment options and fees are available.

Access for an Article: 5.00 (USD)

You can purchase the access for the article to read, download and print its fulltext (PDF, HTML). Access to article will be provide for an unlimited time.

Purchased access does not allow to distribute, copy or reproduce article's materials until the end of the embargo period (3 years) since the publication of the article).

 

Archiving

The journal uses the PKP Preservation Network (PKP PN) to digitally preserve all the published articles. The PKP PN is a part of LOCKSS (Lots of Copies Keep Stuff Safe) program offers decentralized and distributed preservation, seamless perpetual access, and preservation of the authentic original version of the content.

Also, the journal makes full-text archives on the Russian Science Electronic Library (eLibrary.ru) platform.

 

Indexation

The “Neurology Bulletin” is included into the “List of leading scientific journals under review, where principal data of applicants for scientific degree has to be published”, as decreed by State Commission for Academic Degrees and Titles.

The journal is indexed in the following international databases and directory editions:

  • SCIENCE INDEX - Russian Scientific Citation Index is a database, accumulating information on papers by Russian scientists, published in native and foreign titles. The SCIENCE INDEX project is under development since 2005 by “Electronic Scientific Library” foundation (elibrary.ru).
  • Google Scholar
  • Ulrich's Periodical Directory
  • WorldCat

 

Publishing Ethics

The Ethics Policy of the Neurology Bulletin is based on recommendations from international committees:

Reporting standards

The Neurology Bulletin editorial team asks authors of reports of original research to present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.  Reviews (including systematic reviews) should also be accurate and objective.

Authors should use inclusive language that acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Articles should make no assumptions about the beliefs or commitments of any reader, should contain nothing which might imply that one individual is superior to another on the grounds of race, sex, culture or any other characteristic, and should use inclusive language throughout. Authors should ensure that writing is free from bias, for instance by using “he or she” and “his or her” or the gender neutral pronouns “they, their”, and by making use of job titles that are free of stereotyping (e.g. “chairperson” instead of “chairman” and “flight attendant” instead of “stewardess”).

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature.

Data access and retention

The editors reserve the right to request the authors to provide the original (raw) data related to a paper submitted for editorial review.  Authors should be prepared to provide the editors access to such data (consistent with the ALPSP-STM Statement on Data and Databases), and should in any event be prepared to retain such data for a reasonable period of time after publication.

Plagiarism

The Neurology Bulletin does not publish plagiarism, including works containing plagiarism of text, plagiarism of ideas and plagiarism of data.  Manuscript authors must submit completely original work. Reference to the results of work of other authors should be accompanied by citations of the corresponding primary sources, which are to be included in the list of references. The citation of text previously published elsewhere should be reported as direct speech with the quoted text being enclosed in quotation marks and written in italics, accompanied by an obligatory citation of the source. The inclusion of large fragments of borrowed text in the manuscript is unacceptable.

Manuscripts submitted to the Neurology Bulletin are checked for plagiarism through the . If unauthorized borrowings are identified, or if the originality of the text is low (< 85%), the manuscript will be rejected from publication.

Identification of plagiarism of ideas and plagiarism of data is carried out as part of the scientific review, as well as after the publication of a manuscript - upon the fact that readers submit relevant statements. If unauthorized borrowing of data (results of scientific work) or ideas is established, the manuscript (article) will be withdrawn and retracted from publication, even if it has already been published.

Multiplicity, redundancy and simultaneous submission of publications

The Neurology Bulletin considers only original content, i.e. articles that have not been previously published, including in a language other than English. Articles based on content previously made public only on a preprint server, institutional repository, or in a thesis will be considered.  If authors have used their own previously published work, or work that is currently under review, as the basis for a submitted manuscript, they must cite the previous articles and indicate how their submitted manuscript differs from their previous work. Reuse of the authors’ own words outside the Methods should be attributed or quoted in the text. Reuse of the authors’ own figures or substantial amounts of wording may require permission from the copyright holder and the authors are responsible for obtaining this.

Authors should not publish many manuscripts, mainly devoted to the same study, in more than one journal as original works.  Redundant publication, the inappropriate division of study outcomes into more than one article (also known as salami slicing), may result in rejection or a request to merge submitted manuscripts, and the correction of published articles.  Submitting the same manuscript simultaneously to more than one journal will be regarded as a violation of publication ethics. The Neurology Bulletin will reject from publication any manuscripts that are found to be under consideration or previously published in other publications.

The publication of a certain type of articles (for example, clinical guidelines, translated articles) in some cases is permissible (subject to certain conditions). The Neurology Bulletin will consider extended versions of articles published at conferences provided this is declared in the cover letter, the previous version is clearly cited and discussed, there is significant new content, and any necessary permissions are obtained. Duplicate publication of the same, or a very similar, article may result in the retraction of the later article and the authors may incur sanctions.

Authors, when submitting a manuscript for a “secondary” publication, must notify the editors and substantiate in detail its appropriateness. In the case of a "secondary" publication, the settlement of issues related to copyright of the publication is decided individually on a case by case basis.

The general rules for a manuscript as a "secondary" publication are:

  • Citation of a full bibliographic reference to the “primary” publication
  • Preservation of the original bibliography (reference list) of the "primary" work

More information on the acceptable forms of secondary (repeat) publications can be found on ICMJE web pages.

Citation Manipulation

Authors whose submitted manuscripts are found to include citations whose primary purpose is to increase the number of citations to a given author’s work, or to articles published in a particular journal.  Similarly, editors and reviewers must not ask authors to include references merely to increase citations to their own or an associate’s work, to the journal, or to another journal they are associated with.

Source recognition

The contribution of others to the study should always be recognized. Authors should refer to publications that were important in carrying out the scientific work covered in the manuscript. Data obtained unofficially (for example, during a conversation, correspondence or in a process of discussion with third parties) should not be used or presented without the explicit written permission of the source. Information obtained from confidential sources (for example, the provider of a research grant) should not be mentioned in the manuscript without the express written permission of the manuscript authors who are directly related to the relevant confidential sources.

Authorship of publications

The Journal and Publisher assume that all authors agree with the content of the submitted manuscript and that all have given explicit consent to submission.  The Journal and Publisher also assume that consent for submission has been obtained from the responsible authorities at the institute or organization where the work has been carried out.

Authors of publications can be only those people who have made a significant contribution to the formation of the work plan, the development, execution or interpretation of the results of the presented research, as well as to the process of writing the manuscript (including those who conducted scientific and stylistic editing and design in accordance with the requirements of the Journal).

1  First author. The first author in the list of co-authors should be the head of the manuscript authors who took the greatest part in the process of preparing the text and is familiar with the whole process of conducting the scientific work. The leader of the team of authors should become the "author for correspondence", to communicate with the editorial staff and readers (after the publication of the article).

2  Co-authors may be those who made a significant contribution to the preparation of the manuscript text and the study. In those cases where the study participants made a significant contribution in a certain direction in the research project, they should be indicated as persons who made a significant contribution to this study. The authors must make sure that all participants who have made a significant contribution to the study are presented as co-authors. Persons who did not participate in the study should not be listed as co-authors.  All Co-authors should approve the final version of a manuscript and agreed to its submission for publication.

Research subjects and associated risks

The journal publishes only the results of studies conducted in compliance with biomedical ethics and in accordance with GCP (Good Clinical Practice) standards.

Manuscripts should reflect all risks (obvious and potential) to which the subjects of study (people or animals) were exposed: exposure to chemicals (including drugs), procedures or equipment, and other situations that could be harmful to health or be dangerous to the life of the subjects of study.

If living people or animals are the research subjects in the experimental study, the authors should reflect in their manuscript that all stages of the study were carried out in accordance with the law and regulatory documents. Authors should also provide information that the study protocol was reviewed by an ethics committee with an obligatory indication of the name of the committee (or organization by which the committee was created), the date and reference number of the minutes of the meeting at which the study was approved. The editors have the right to require from the team the author certified copies of the relevant protocols.

All clinical trials should be conducted in accordance with the ethical principles of Good Clinical Practice and comply with the requirements of Federal Law No. 61 “On the Circulation of Medicines” (2010), as well as other applicable laws of the Russian Federation.

Research involving human embryos, gametes, and stem cells

Manuscripts that report experiments involving the use of human embryos and gametes, human embryonic stem cells and related materials, and clinical applications of stem cells must include confirmation that all experiments were performed in accordance with relevant guidelines and regulations.

The manuscript should include an ethics statement identifying the institutional or national research ethics committee (including the name of the ethics committee) approving the experiments and describing any relevant details. Authors should confirm that voluntary informed consent was obtained from all recipients and donors of cells or tissues, where necessary, and describe the conditions of donation of materials for research, such as human embryos or gametes. Copies of approval and redacted consent documents may be requested by the Journal.

We encourage authors to follow the principles laid out in the 2016 ISSCR Guidelines for Stem Cell Research and Clinical Translation.

In deciding whether to publish papers describing modifications of the human germline, the Journal is guided by safety considerations, compliance with applicable regulations, as well as the status of the societal debate on the implications of such modifications for future generations. In case of concerns regarding a particular type of study the Journal may seek the advice from the Springer Nature Research Integrity Group (SNRIG).

The decision to publish a paper is the responsibility of the Editor-in-Chief of the Journal.

Disclosure of conflicts of interest

All authors are obliged to disclose (declare in the appropriate section of the manuscript) financial or other obvious or potential conflicts of interest that may be perceived as having an impact on the results or conclusions presented in the work.

Examples of potential conflicts of interest to be disclosed:

  • receiving financial reward for participating in a study or writing a manuscript
  • any connection with organizations that have a direct interest in the subject of the study or review (for example: work under contract, consultation, stock ownership, receiving fees or royalties, providing expert opinion)
  • patent application or registration of a patent for research results (copyright, etc.)
  • obtaining financial support for any of the stages of the study or manuscript writing (including grants and other financial support)
  • close personal connections
  • beliefs or activism, for example, political or religious, relevant to the work
  • competitors or someone whose work is critiqued.

Explicit and potential conflicts of interest should be disclosed as early as possible.

Information about conflicts of interest received from the authors of manuscripts is not provided to reviewers and is available only to the editorial board when deciding on the publication of the manuscript. Information about conflicts of interest is published as part of the full article.

Significant errors in published works

If the author finds significant errors or inaccuracies in the publication, the author must promptly inform the editorial office of the journal or the publisher in order to retract the publication or to correct errors. If the editorial board or the publisher receives substantiated information from a third party that the publication contains significant errors, the author is obliged to retract the work or correct the errors as soon as possible, or to refute the statement of errors by presenting the necessary evidence to the editorial office.  When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s).  Errors by the authors may be corrected by a published corrigendum, and errors by the publisher by a published erratum.

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

If the Neurology Bulletin becomes aware of breaches of our publication ethics policies the following sanctions may be applied:

  • Rejection of the manuscript and any other manuscripts submitted by the author(s).
  • Not allowing submission for 1–3 years.
  • Prohibition from acting as an editor or reviewer.

The Neurology Bulletin may apply additional sanctions for severe ethical violations.

 

Corrections, Retractions, and Editorial expressions of concern Policies

Neurology Bulletin is committed to uphold the integrity of the literature and publishes Errata (Corrections), Expressions of Concerns or Retraction Notices dependent on the situation and in accordance with the COPE Retraction Guidelines. In all cases, these notices are linked to the original article.

When an author discovers a significant error or inaccuracy in his/her own published work, it is the authors obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.

If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

When errors are identified in published articles, the publisher will consider what action is required and may consult the editors and the authors’ institution(s). 

Errors by the authors may be corrected by a corrigendum, and errors by the publisher — by an erratum (see more).

If there are errors that significantly affect the conclusions or there is evidence of misconduct, this may require retraction or an expression of concern following the COPE Retraction Guidelines. All authors will be asked to agree to the content of the appropriate notice.

According to the rules of the Council on Ethics of Scientific Publications of Association of Science Editors and Publishers, the grounds for article retraction are:

  • detection of plagiarism in the article;
  • detection of falsifications (for example, manipulation of experimental data);
  • detection of serious errors that cast doubt on scientific value of the article;
  • incorrect list of authors;
  • duplication of the article in several journals;
  • republishing the article without the author’s consent;
  • concealment of conflict of interest and other violations of publication ethics;
  • the fact that the article hasn’t been peer reviewed.

After the decision to retract the article is made, the editor-in-chief informs its authors, indicating the reason and date of retraction. The article remains on the journal’s site as part of the corresponding journal issue, but is marked “retracted” with the retraction date (the mark is placed on top of the text of the article and in the table of contents); in addition, a message about retraction is placed in the news section of the site, and the chief editor sends information about the article retraction to all online libraries and databases in which the journal is indexed.

Information on COPE Retraction Guidelines can be found here: Retraction Guidelines

More details can be observed on the Eco-Vector CrossMark Policy page: http://doi.org/10.17816/crossmarkpolicy2018

 

Sources of Income and Advertising Policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

  1. The Neurology Bulletin generate revenue for Publisher (Eco-Vector) from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Publisher staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of Neurology Bulletin editors and Publisher's advertising managers are separate.
  4. In Neurology Bulletin professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content in Neurology Bulletin, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. Neurology Bulletin editorial team has the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the Publisher organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the Neurology Bulletin editors and Eco-Vector’s adverticement managers. In no case shall separate agreements with Eco-Vector or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
  • Alcohol
  • Tobacco
  • Weapons, firearms, ammunition
  • Fireworks
  • Gambling and lottery
  • Pornography or related themes
  • Political and religious advertisements
  • Advertisements that claim to have a “miracle” cure or method
  • Advertisements that make unsubstantiated health claims for the products advertised
  • Advertisements directed at children
  1. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  2. All advertisements are accepted and published by Eco-Vector in Neurology Bulletin on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  3. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers and Neurology Bulletin editorial team members, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  4. Any references to Eco-Vector and Neurology Bulletin or their products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  5. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  6. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  7. While Neurology Bulletin welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  8. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  9. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  10. Advertisements may not imply endorsement by the Neurology Bulletin or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  11. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  12. The following online advertising formats are prohibited:
  • Pop-ups and floating advertisements.
  • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
  • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
  • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Neurology Bulletin published advertising policies are not exhaustive and are subject to change at any time without notice.

Eco-Vector partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/.

 

Publication fees, APC

Publication in Neurology Bulletin is free of charge for all authors.

The Neurology Bulletin charge no obligatory publication fees from authors - including those of peer-review management, manuscript processing, journal production, online hosting and archiving.

There are some paid options for authors wich are not influence over the editorial decisions: publication in Open Access and Fast-Track editorial workflow. Details can be observed here.

 

Adverticement and reprint policy

Our advertising policy is consistent with the principles mentioned in the Recommendations on Publication Ethics Policies for Medical Journals which issued by the World Association of Medical Editors (WAME).

http://www.wame.org/recommendations-on-publication-ethics-policie

  1. The Eco-Vector’s journals generate revenue from advertising, which creates a potential conflict of interest. Editors’ decisions do not depend on the cost of advertising or producing reprints. Advertisers and sponsors have no influence over the editor’s decisions, regardless of the terms of advertising or other agreements.
  2. All advertisements are subject to the approval of the Eco-Vector’s staff, which reserves the right to reject or cancel any advertisement at any time.
  3. The functions of editors and advertising managers in Eco-Vector’s journals are separate.
  4. In Eco-Vector’s journals professional (physician-directed) publications and web sites, the intentional placement of advertising adjacent to articles discussing the company or product that is the subject of the advertisement is prohibited. Advertising content must be distinguished from editorial and other materials so that the difference between them is obvious.
  5. Eco-Vector will not publish “advertorial” content, and sponsored supplements must be clearly indicated as such. If a supplement did not undergo peer review or underwent a peer review-process different from the rest of the journal that should be explicitly stated.
  6. All Eco-Vector’s journals have the right to refuse any advertisement that, in its sole discretion, is incompatible with its mission or inconsistent with the values of members, the publication/web site or the organization as a whole, and to stop accepting any advertisement previously accepted. Advertisements are subject to review by the editors and others at the Eco-Vector’s journals. In no case shall separate agreements with Eco-Vector’s journals or its subsidiaries supersede this policy.
  7. Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Eco-Vector’s staff request its removal.
  8. Advertising for the following categories is prohibited:
    • Alcohol
    • Tobacco
    • Weapons, firearms, ammunition
    • Fireworks
    • Gambling and lottery
    • Pornography or related themes
    • Political and religious advertisements
    • Advertisements that claim to have a “miracle” cure or method
    • Advertisements that make unsubstantiated health claims for the products advertised
    • Advertisements directed at children
  9. Advertisements may not be deceptive or misleading, and must be verifiable. Advertisements should clearly identify the advertiser and the product or service being offered. Exaggerated or extravagantly worded copy will not be allowed. Advertisements will not be accepted if they appear to be indecent or offensive in either text or artwork, or if they relate to content of a personal, racial, ethnic, sexual orientation, or religious nature.
  10. All advertisements are accepted and published by Eco-Vector on the warranty of the advertisement agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.
  11. In consideration of publication of an advertisement, the advertiser and the advertisement agency, jointly and severally, agree to indemnify and hold harmless Eco-Vector, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.
  12. Any references to Eco-Vector or its products or services in advertisements, promotional material, or merchandising by the advertiser or agency is subject to Eco-Vector’s written approval for such use.
  13. All advertisements for drug-specific campaigns must comply with the relevant Russian legislation that regulates advertising. Advertisers should make available to Eco-Vector the marketing authorization and summary of product characteristics when submitting their advertisement. In the case of drug advertisements, proprietary names of pharmaceutical products must be accompanied by the chemical, generic, or official name; the quantity of all active substances must be stated along with the recommended dosage. Each page of an advertisement for a prescription-only medicine should be clearly labeled as intended for health professionals.
  14. Advertisements for products not approved by the FDA or the Ministry of Health of Russian Federation that make any kind of health claims must carry the following disclaimer: “These statements have not been evaluated by the Food and Drug Administration and/or the Ministry of Health of Russian Federation. This product is not intended to diagnose, treat, cure or prevent any disease.”
  15. While Eco-Vector’s journals welcomes and encourages information-rich advertising, advertisements, advertising icons and advertiser logos must be clearly distinguishable from editorial content and may require special labeling to distinguish them as such. All advertisements must clearly and prominently identify the advertiser by trademark or signature.
  16. Reprints should be published only in the form in which they were originally published in the journal (including subsequent corrections), so there should be no additions or changes in them.
  17. Publisher is not responsible for incidental or consequential damage for errors in displaying or printing an advertisement.
  18. Advertisements may not imply endorsement by the Eco-Vector’s journals or its publications/web sites except as may be provided for under a separate agreement — in which case advertising must be pre-approved to ensure adherence to the letter and spirit of that separate agreement.
  19. The full rules for any market research or promotion associated with an advertisement must be displayed in the advertisement or available via a prominent link.
  20. The following online advertising formats are prohibited:
    • Pop-ups and floating advertisements.
    • Advertisements that collect personally identifiable information from visitors without their knowledge or permission.
    • Advertisements that extend across or down the page without the visitor having clicked or rolled-over the advertisement.
    • Advertisements that send visitors to another site without the visitor having clicked the advertisement.

Eco-Vector’s journals published advertising policies are not exhaustive and are subject to change at any time without notice.

We partner with third-party advertising companies to serve ads and/or collect certain information when you visit our website. These companies may use cookies or web beacons to collect non-personally identifiable information [not including your name, address, email address or telephone number] during your visit to this website to help show advertisements on other websites also likely to be of interest to you.

For contact with the Advertisement department of the Publisher, please, follow the link https://eco-vector.com/


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies